Highlights & Updates
05
Oncode Accelerator: Highlights & Updates
In this overview, we present a snapshot of our progress, scientific updates from consortium partners, media attention and major milestones from the first months of Oncode Accelerator.
National Growth Fund Recognizes Impact of Oncode Accelerator
The Dutch National Growth Fund issued a positive recommendation for a second funding round of €123 million for the Oncode Accelerator program, confirming confidence in the program’s approach and impact.
Read more
Fast and Scalable Data Delivery to the Netherlands Cancer Registry
R(H)ONDA is a new infrastructure that supports near real-time enrichment of the Netherlands Cancer Registry (NCR) with electronic health records data - key for timely surveillance of cancer treatment.
Read more
Where Technology Meets Biology: Creating New Possibilities for Cancer Vaccines
A new method called hybrid fragmentation mass spectrometry is allowing scientists to better understand the language and identity of proteins – which could ultimately help them to develop new cancer therapies.
Read more
Sarcoma Organoids Help Find Targeted Treatment
Researchers at the Princess Máxima Center have developed a biobank of lab-grown mini-tumors of rare and aggressive bone and soft tissue tumors, enabling faster and more targeted drug research.
Read more
With the support of several Oncode Accelerator collaborators and other experts, FAST created a renewed and expanded guidebook for developing ATMPs in the Netherlands.
Read more
At the end of 2024, OncoZON signed a letter of intent to participate in this automated data flow.
Read more
Oncode Accelerator was incorporated
into the longstanding Memorandum of Understanding between Oncode Institute and Cancer Research Horizons.
Read more
Targeted IgA Against Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer for which immunotherapeutic efficacy remains limited. A new study shows the potential of monoclonal antibodies of the IgA isotype as a therapeutic option.
Read more
Promising Results from Vaccination Study for Non-Small Cell Lung Cancer
Long-term collaborative efforts have led to promising results from a first-in-human study evaluating a new therapeutic vaccine for immune-escaped tumors.
Read more
In Search of Beautiful Molecules
This article argues that the goal for generative AI in drug development should not be simply to create "novel" or “desirable” molecules, but "beautiful" molecules.
Read more
Using Patient-Derived Organoids to Identify New Therapies
A recent publication used patient-derived organoids to assess if traits that make cells radiation resistant could be exploited to find new therapeutic options.
Read more
Shifting the Balance of γδT Cells for Cancer Immunotherapy
A new article presents an overview of the current knowledge on γδT cells and their unique receptor systems, highlighting strategies to harness them for more effective therapies.
Read more
A New Tool for Uncovering Mechanisms Underlying Health and Disease
MR-link-2 is a promising new tool for researchers aiming to understand molecular mechanisms that drive health and disease in humans.
Read more
Share this article
Next Article